Drug Research
Hovione and GEA announce a strategic collaboration to advance...
Hovione and GEA announced a strategic collaboration to advance Continuous Tableting. This partnership stemmed from a successful customer-supplier relationship spanning several years. It combines GEA´s...
News
Hyperparathyroidism: Symptoms, Causes and Treatment
Hyperparathyroidism is an extremely prevalent endocrine disorder. Recent studies reveal that about 80% of people in Western countries suffer from parathyroids. Additionally, about 1,00,000 people...
Clinical Trials
Canadian And US Pharma Firms To Test Psychedelic Drugs...
To take advantage of the UK's quick medication approval procedures, the North American psychedelic drug companies Mindset, PharmAla, Mydecine, and Psyence have inked a contract...
News
Swiss and French Health Authorities Expand Recommendations for Use...
Novavax announced that Switzerland’s Federal Office of Public Health (FOPH) and France’s Haute Autorité de Santé (HAS) have expanded their recommendations for use of Nuvaxovid™(NVX-CoV2373)...
News
Evaxion and ExpreS2ion initiate research collaboration on a novel...
Evaxion Biotech A/S , a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies, announces that the Company has signed a Vaccine Discovery Collaboration...
Clinical Trials
Immix Biopharma Announces Patient Dosing in Ongoing Phase 1b/2a...
Immix Biopharma, Inc, a biopharmaceutical company pioneering Tissue-Specific Therapeutics (TSTx)TM targeting oncology and immuno-dysregulated diseases, announced patient dosing in its ongoing Phase 1b/2a IMX-110 monotherapy...
Drug Research
HitGen Announces Research Agreement with Nitrase Therapeutics Focused on...
HitGen Inc announced that it has entered into a research agreement with Nitrase Therapeutics, Inc. , a biopharmaceutical company deploying its NITROME platform to build...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.